Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
pVnR0uPzUPG6npBf
Écouter
